Health Biotechnology

First-in-class therapy development addressing unmet medical needs in the oncology space

A novel combination treatment effective against all multidrug-resistant pathogens deemed as a critical priority by the WHO

Anti-microRNAs designed for the treatment of diseases with unmet needs.

Next generation of insulin-producing cell transplantation

First-in-class disease-modifying drug for chronic airway disorders

Biotechnology platform designed to create intelligence-augmenting services for precision oncology research and drug development

Developing novel treatments for medical conditions with unmet needs

Clinical-stage biotechnology disease modifying therapies for neurodegenerative diseases

Treating cancer by targeting tumor viruses within the human genome

Innovative treatments for chronic pain disorders and hearing loss.

Next-generation biologics to treat wounds in skin and mucosa

Developing a portfolio of drug candidates to address several types of severe cancers

Driving superior clinical benefits for patients in the treatment of cancer

Revolutionary vaccines to prevent pandemic and seasonal outbreaks of respiratory viral infections